Thermo Fisher Scientific & Pfizer partner to expand localized access to next generation sequencing-based testing for cancer patients in international markets
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
Bayer opens first Co.Lab Life science incubator in Cambridge
- Details
- Category: Bayer
![Bayer Bayer](/images/logo/bayer.png)
Roche launches Institute of Human Biology to accelerate breakthroughs in R&D by unlocking the potential of human model systems
- Details
- Category: Roche
![Roche Roche](/images/logo/roche.png)
U.S. FDA approves PREVNAR 20®, Pfizer's 20-valent pneumococcal conjugate vaccine for infants and children
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/logo/pfizer.png)
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/logo/gsk.png)
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/logo/astrazeneca.png)
More Pharma News ...
- FDA accepts Pfizer's Supplemental New Drug Applications for BRAFTOVI + MEKTOVI
- Novo Nordisk Foundation to support crucial education of health professionals in India and East Africa with up to DKK 1bn (USD 140m)
- Bayer Pharmaceuticals accelerates innovations for patients
- Novartis shares Zolgensma long-term data demonstrating sustained durability up to 7.5 years post-dosing; 100% achievement of all assessed milestones in children treated prior to SMA symptom onset
- CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders
- Insilico Medicine brings AI-powered "ChatPandaGPT" to its target discovery platform
- BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial